Biomet
JNJ continues to pay hefty integration charges on Synthes deal
Biomet’s Q1 profits plunge despite sales increases
Biomet today reported a 77% profit slide for its fiscal 1st quarter, despite posting sales gains across its all but 1 line of orthopedic implants.
Peripherals transition team named in Medtronic, Covidien merger | The week in medtech M&A
EU to extend Zimmer, Biomet probe
Zimmer and Biomet update on their mega-merger
Second suitor cedes the field early to Zimmer | Medtech Wall Street news for the week of September 15, 2014
Second suitor cedes the field early to Zimmer | The week in medtech M&A
Second suitor ceded early to Zimmer in chase for Biomet
Japan probes Biomet-Zimmer merger
Biomet settles with patent troll, loses European bone cement suit
Biomet said this week that it settled a portion of a patent infringement case with a notorious patent troll and lost a trade secrets theft lawsuit brought in Germany over some of its bone cements.